Tapentadol Hydrochloride

CAS 175591-09-0 10 current recordsSmall Molecule

Who holds supplier records for Tapentadol Hydrochloride? 10 organisations hold a current record for Tapentadol Hydrochloride: an active US FDA Type II Drug Master File or a CEP. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), United States (1), Germany (1) and China (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Tapentadol Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/tapentadol-hydrochloride

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    6 of the 9 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 4 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Tapentadol Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India6United States1Germany1China1Country not recorded for 1
Need Tapentadol Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Tapentadol Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
VIYASH SCIENTIFIC LIMITED HyderabadIN
CEP 2022-252 - Rev 02
Tapentadol hydrochloride, Form-A
Jul 2026—
AMI LIFESCIENCES PRIVATE LIMITED VadodaraIN
CEP 2021-290 - Rev 01
Tapentadol hydrochloride
Mar 2026Inspected Oct 2025
Slovakia
ARENE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2024-524 - Rev 00
Tapentadol hydrochloride
Jun 2025—
YICHANG HUMANWELL PHARMACEUTICAL CO., LTD. YichangCN
CEP 2024-119 - Rev 00
Tapentadol hydrochloride
Feb 2025Inspected Jul 2026
Hungary
VIRUPAKSHA ORGANICS LIMITED HyderabadIN
CEP 2023-142 - Rev 00
Tapentadol hydrochloride
Oct 2024—
Grunenthal GmbH AachenDE
R0-CEP 2021-390 - Rev 00
Tapentadol hydrochloride
Oct 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Tapentadol Hydrochloride is an opioid analgesic and is used for the treatment of moderate to severe acute pain. It possesses a dual mode of action as a mu-opioid receptor agonist and norepinephrine reuptake inhibitor.

Chemical identity

IUPAC name
3-[(2R,3R)-1-(dimethylamino)-2-methylpentan-3-yl]phenol;hydrochloride
Canonical SMILES
CC[C@@H](C1=CC(=CC=C1)O)[C@@H](C)CN(C)C.Cl
InChIKey
ZELFLGGRLLOERW-YECZQDJWSA-N
Synonyms
Nucynta API, bn-200 hydrochloride, cg-5503 hydrochloride, cg5503 hydrochloride, dea no. 9780 (hydrochloride), nucynta, palexia, tapentadol hcl

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Opioid Agonist
Mechanism of action
Opioid Agonists

Therapeutic areas

Pain ManagementAnalgesia

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Tapentadol Hydrochloride?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Tapentadol Hydrochloride: Alkem Laboratories Limited (India), CURIA MISSOURI INC, MSN Organics Private Limited (India), NORAMCO INC (United States), AMI LIFESCIENCES PRIVATE LTD (India), Arene Life Sciences Limited (India), Grünenthal GmbH (Germany) and VIRUPAKSHA ORGANICS LTD (India), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Tapentadol Hydrochloride Drug Master Files are active?

Alkem Laboratories Limited (DMF 26519, 31435), CURIA MISSOURI INC (DMF 26490), MSN Organics Private Limited (DMF 41316) and NORAMCO INC (DMF 21084). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

Does Tapentadol Hydrochloride have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Tapentadol Hydrochloride on the EDQM register, including VIYASH SCIENTIFIC LIMITED Hyderabad (IN), AMI LIFESCIENCES PRIVATE LIMITED Vadodara (IN), ARENE LIFE SCIENCES PRIVATE LIMITED Hyderabad (IN), YICHANG HUMANWELL PHARMACEUTICAL CO., LTD. Yichang (CN), VIRUPAKSHA ORGANICS LIMITED Hyderabad (IN) and Grunenthal GmbH Aachen (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Tapentadol Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Tapentadol Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.